Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine-busulfan-cyclophosphamide-based conditioning.
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric transplantation"
DOI: 10.1111/petr.14181
Abstract: BACKGROUND Juvenile myelomonocytic leukemia (JMML) is a rare hematological malignancy in young children and can only be cured through the allogeneic stem cell transplantation. PROCEDURE We have retrospectively analyzed the outcomes of nine children with… read more here.
Keywords: juvenile myelomonocytic; nine children; cord blood; transplantation ... See more keywords